Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose:
A hallmark of systemic autoimmune diseases, such as systemic lupus erythematotsus (SLE), is the increased expression of interferon (IFN) type I inducible genes, the so-called IFN type I signature. Recently, a novel T helper 17 subset (Th17 cells), which produces IL-17A, IL-17F, and IL-22, has also been implicated in autoimmune diseases. We investigated a possible link between these two pro-inflammatory immune pathways in SLE.
Methods:
25 SLE patients and 15 healthy controls (HC) were included. SLE patients were divided into an IFN type I signature negative (n=9) and positive (n=16) group as assessed by mRNA expression of IFN type I inducible genes. Peripheral expression of Th17 cytokines IL-17A, IL-17F and IL-22 by CD4+CCR6+ memory T cells was measured by flow cytometry and compared between IFN type I signature positive and negative patients and HC.
Results:
Increased fraction of IL-17A and IL-17A/IL-17F double producing CCR6+ cells was found in IFN type I positive patients compared with IFN type I negative patients and HC. The expression of IL-17A and IL-17F within CCR6+ cells correlated significantly with IFN scores. In addition, we found a significant correlation between BAFF and IL-21 producing CCR6+ cells.
Conclusion:
Here we show for the first time a correlation between IFN type I activation and expression of the Th17 cytokines in SLE patients. These data give new insight into the pathogenesis of SLE with possible implications for treatment.
Disclosure:
O. B. J. Corneth,
None;
Z. Brkic,
None;
C. G. van Helden-Meeuwsen,
None;
R. J. E. M. Dolhain,
None;
N. I. Maria,
None;
S. M. J. Paulissen,
None;
N. Davelaar,
None;
J. P. van Hamburg,
None;
P. L. Van Daele,
None;
V. A. Dalm,
None;
M. van Hagen,
None;
M. A. Versnel,
None;
E. Lubberts,
None.
« Back to 2013 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-helper-17-cells-and-interferon-type-i-partners-in-crime-in-sle/